Zyloprim Drug Card
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Zyloprim Drug Card as PDF for free.
More details
- Words: 301
- Pages: 1
NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name Allopurinol Peak 1-2 weeks
Trade Name Zyloprim Onset 1-2 days
Classification Dose Route Time/frequency Antigout agents, 100 mg PO Q AM xanthine ixidase inhibitors Duration Normal dosage range 1-3 weeks 100 mg/day, for renal impairment reduce to 50 mg/day
Why is your patient getting this medication Treatment of secondary hyperuricemia, which may occur during treatment of tumors or leukemias(breast cancer).
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Treatment of secondary hyperuricemia, which may occur during treatment of tumors or leukemias(breast cancer). Inhibits the production of uric acid by inhibiting the action of xanthine oxidase, lowers serum uric acid levels.
Nursing Implications (what to focus on) Contraindications/warnings/interactions – Hypersensitivity, use cautiously in acute attacks of gout, renal insufficiency, dose reduction
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this pt.
Lab value alterations caused by medicine – Lower uric acid levels. May cause hypoglycemia, monitor blood glucose, may cause increase serum alkaline phosphatase, bilirubin, AST and ALT levels, BUN, serum creatine, and CCr. Decrease CBC and platelets may indicate bone marrow depression. Be sure to teach the patient the following about this medication Increase fluid intake, report skin rash, blood in urine or flu like symptoms, follow up exams.
Nursing Process- Assessment (Pre-administration assessment) I & O, Decreased kidney function can cause drug accumulation and toxic effects. Adequate fluid intake 2500 – 3000 ml/day. Assess for rash.
Common side effects – rash (d/c drug at first sign of rash)
Assessment Why would you hold or not give this med? Rash, which pt does have.
Evaluation Check after giving Decreased serum and urinary uric acid levels.
Trade Name Zyloprim Onset 1-2 days
Classification Dose Route Time/frequency Antigout agents, 100 mg PO Q AM xanthine ixidase inhibitors Duration Normal dosage range 1-3 weeks 100 mg/day, for renal impairment reduce to 50 mg/day
Why is your patient getting this medication Treatment of secondary hyperuricemia, which may occur during treatment of tumors or leukemias(breast cancer).
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Treatment of secondary hyperuricemia, which may occur during treatment of tumors or leukemias(breast cancer). Inhibits the production of uric acid by inhibiting the action of xanthine oxidase, lowers serum uric acid levels.
Nursing Implications (what to focus on) Contraindications/warnings/interactions – Hypersensitivity, use cautiously in acute attacks of gout, renal insufficiency, dose reduction
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this pt.
Lab value alterations caused by medicine – Lower uric acid levels. May cause hypoglycemia, monitor blood glucose, may cause increase serum alkaline phosphatase, bilirubin, AST and ALT levels, BUN, serum creatine, and CCr. Decrease CBC and platelets may indicate bone marrow depression. Be sure to teach the patient the following about this medication Increase fluid intake, report skin rash, blood in urine or flu like symptoms, follow up exams.
Nursing Process- Assessment (Pre-administration assessment) I & O, Decreased kidney function can cause drug accumulation and toxic effects. Adequate fluid intake 2500 – 3000 ml/day. Assess for rash.
Common side effects – rash (d/c drug at first sign of rash)
Assessment Why would you hold or not give this med? Rash, which pt does have.
Evaluation Check after giving Decreased serum and urinary uric acid levels.
Related Documents
Zyloprim Drug Card
December 2019 12
Zyloprim
May 2020 0
Drug Card
November 2019 32
Drug Senna Drug Card
May 2020 19
Drug Card Darvacet
November 2019 9